04:11 PM EST, 12/19/2024 (MT Newswires) -- Andrew Guggenhime, President and CFO, on December 18, 2024, sold 8,000 shares in Vaxcyte ( PCVX ) for $710,249. Following the Form 4 filing with the SEC, Guggenhime has control over a total of 109,491 shares of the company, with 109,491 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649094/000164909424000126/xslF345X05/wk-form4_1734642427.xml